Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD) [Phase 4]
Phase 4 multicenter randomized trial comparing esomeprazole 20 mg and 40 mg daily to placebo for heartburn and sleep disturbances in gastroe…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Validation of RDQ Questionnaire [Phase 4]
Phase 4 study validating the Reflux Disease Questionnaire (RDQ) for gastroesophageal reflux disease has completed. The results support its u…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD) [Phase 3]
A Phase 3 multicenter randomized trial evaluating esomeprazole 20 mg once daily versus placebo for the resolution of upper abdominal pain in…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: ASTERIX: Low Dose ASA and Nexium [Phase 3]
Phase 3 trial ASTERIX investigating low-dose aspirin and esomeprazole for gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD [Phase 4]
Phase 4 clinical trial evaluating 24-hour intragastric pH profiles after administration of esomeprazole, lansoprazole, and pantoprazole in H…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: PPI Sequencing Study [Phase 4]
A Phase 4 clinical trial evaluating proton pump inhibitor sequencing for gastroesophageal reflux disease sponsored by AstraZeneca has comple…
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD
A Canadian multi-centre clinical trial sponsored by AstraZeneca evaluating symptom burden and clinical management in subjects with gastroeso…
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Importance of Non-Acid Reflux in Asthma in Children
The trial investigated how non-acid reflux may influence asthma in children. The study (NCT00200980) has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Esomeprazole in PPI Failures - IMPROVE [Phase 4]
Phase 4 IMPROVE trial evaluating esomeprazole in patients with gastroesophageal reflux disease who failed prior PPI therapy has been complet…
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) [Phase 4]
This Phase 4, open-label study evaluated once-daily esomeprazole 40 mg in patients with GERD. The trial has completed.
-
FDA approval · 2009-02-27FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)
FDA approved a supplemental application to approve Walgreens' Cimetidine 200 Acid Reducer as a generic cimetidine product.
-
CLINICAL_TRIALS trial_result · 2009-02-26Clinical Trial Update: Laparoscopic Nissen Fundoplication Comparing Division Versus Non-Division of Short Gastric Vessels [NA]
This trial compares division versus non-division of short gastric vessels during laparoscopic Nissen fundoplication for gastroesophageal ref…
-
CLINICAL_TRIALS trial_result · 2009-02-25Clinical Trial Update: Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD [Phase 4]
A Phase 4 trial comparing Nexium 40 mg once daily to Prevacid 30 mg twice daily for control of severe gastroesophageal reflux disease has co…
-
CLINICAL_TRIALS trial_result · 2009-02-10Clinical Trial Update: Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study
A completed prospective study evaluating guidelines for gastroesophageal reflux disease (GERD) conducted under the Spanish Gastroenterology …
-
FDA approval · 2009-01-30FDA Approved: DEXILANT — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approved Dexilant (dexlansoprazole) under an original application for the treatment of gastroesophageal reflux disease, including healin…
-
CLINICAL_TRIALS trial_result · 2009-01-26Clinical Trial Update: Nexium RESPONSE Trial [Phase 4]
The Nexium RESPONSE trial, a Phase 4 study evaluating esomeprazole for gastroesophageal reflux disease, has completed.
-
FDA approval · 2009-01-21FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for omeprazole filed by Quallent Pharmaceuticals Health LLC under an ANDA.
-
FDA approval · 2009-01-21FDA Approved: OMEPRAZOLE — Original Application (Sandoz Inc)
FDA approved the original application for omeprazole from Sandoz Inc, authorizing a generic version of this proton pump inhibitor.
-
FDA approval · 2008-12-01FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) by Covis Pharma US, Inc. to update and/or expand the product lab…
-
FDA approval · 2008-11-24FDA Approved: ACID CONTROLLER — Supplemental Application (H E B)
FDA approved a supplemental application for ACID CONTROLLER (famotidine) from H E B. The approval expands the product's labeling/indications…
-
CLINICAL_TRIALS research · 2008-11-18Clinical Trial Update: Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France
This update reports the prevalence of gastroesophageal reflux disease among children and adolescents in France based on data from the comple…
-
FDA approval · 2008-10-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for metoclopramide from ANI Pharmaceuticals, Inc., for an already approved generic product. This…
-
CLINICAL_TRIALS trial_result · 2008-09-17Clinical Trial Update: The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients
AstraZeneca completed a clinical trial evaluating whether lifestyle adjustments prior to medical treatment modify outcomes in patients with …
-
CLINICAL_TRIALS trial_result · 2008-07-28Clinical Trial Update: Gatekeeper European 005
The Gatekeeper European 005 clinical trial sponsored by Medtronic Neuro investigating gastroesophageal reflux disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-07-16Clinical Trial Update: A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERD [NA]
Clinical trial evaluating endoscopic full-thickness plication for gastroesophageal reflux disease was terminated. No efficacy results are pr…